Neil G. Mitchill Jr.
Known title: EVP, Chief Financial OfficerCIK: 0001633746
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
RTX Faces Q3 Earnings Test Amid Defense Sector Scrutiny. Attention is turning to RTX as the defense sector prepares for its Q3 earnings season. Recent reports highlight fresh contract wins and a potential valuation gap, while analysts compare its dividend profile to peers like Lockheed Martin. The stock is currently trading near key technical support levels, reflecting a cautious market stance ahead of the upcoming results.
Transaction History
| MMM | ▲ Buy | Grant | 1,360 | $195K | 5/12/2026 | View on chart |
| RTX | ▲ Buy | Option Exercise | 10,000 | $760K | 2/19/2026 | View on chart |
| RTX | ▲ Buy | Option Exercise | 9,394 | $714K | 2/19/2026 | View on chart |
| RTX | ▼ Sell | Other | 3,473 | $714K | 2/19/2026 | View on chart |
| RTX | ▼ Sell | Other | 3,697 | $760K | 2/19/2026 | View on chart |
| RTX | ▼ Sell | Open Market | 5,921 | $1.2M | 2/19/2026 | View on chart |
| RTX | ▼ Sell | Open Market | 6,303 | $1.3M | 2/19/2026 | View on chart |
| RTX | ▼ Sell | Open Market | 23,531 | $4.8M | 2/19/2026 | View on chart |
| RTX | ▲ Buy | Grant | 42,618 | $8.5M | 2/8/2026 | View on chart |
| RTX | ▼ Sell | Tax Withholding | 19,087 | $3.8M | 2/8/2026 | View on chart |
| MMM | ▲ Buy | Grant | 314 | $52K | 2/6/2026 | View on chart |
| RTX | ▼ Sell | Other | 4,089 | $736K | 10/24/2025 | View on chart |
| RTX | ▼ Sell | Open Market | 4,849 | $874K | 10/24/2025 | View on chart |
| RTX | ▲ Buy | Option Exercise | 8,938 | $736K | 10/24/2025 | View on chart |
| RTX | ▼ Sell | Open Market | 16,118 | $2.1M | 2/27/2025 | View on chart |
| RTX | ▼ Sell | Tax Withholding | 11,960 | $1.5M | 2/15/2025 | View on chart |
| RTX | ▲ Buy | Grant | 28,078 | $3.4M | 2/15/2025 | View on chart |
| RTX | ▲ Buy | Option Exercise | 11,236 | $798K | 7/30/2024 | View on chart |
| RTX | ▼ Sell | Open Market | 4,322 | $499K | 7/30/2024 | View on chart |
| RTX | ▼ Sell | Other | 6,914 | $798K | 7/30/2024 | View on chart |
| RTX | ▼ Sell | Tax Withholding | 1,848 | $187K | 4/26/2024 | View on chart |
| RTX | ▼ Sell | Tax Withholding | 7,366 | $747K | 4/26/2024 | View on chart |
| RTX | ▲ Buy | Grant | 15,895 | $1.6M | 4/26/2024 | View on chart |
| RTX | ▲ Buy | Option Exercise | 3,986 | $0 | 4/26/2024 | View on chart |
| RTX | ▲ Buy | Option Exercise | 8,907 | $0 | 2/8/2024 | View on chart |
| RTX | ▼ Sell | Tax Withholding | 2,914 | $265K | 2/8/2024 | View on chart |
| RTX | ▼ Sell | Tax Withholding | 5,488 | $500K | 2/8/2024 | View on chart |
| RTX | ▲ Buy | Grant | 11,841 | $1.1M | 2/8/2024 | View on chart |
| RTX | ▲ Buy | Option Exercise | 9,023 | $731K | 2/7/2024 | View on chart |
| RTX | ▲ Buy | Option Exercise | 5,873 | $502K | 2/7/2024 | View on chart |
| RTX | ▼ Sell | Open Market | 1,545 | $143K | 2/7/2024 | View on chart |
| RTX | ▼ Sell | Other | 13,351 | $1.2M | 2/7/2024 | View on chart |
| RTX | ▲ Buy | Option Exercise | 10,178 | $0 | 2/4/2023 | View on chart |
| RTX | ▼ Sell | Tax Withholding | 3,310 | $319K | 2/4/2023 | View on chart |
| RTX | ▼ Sell | Tax Withholding | 5,501 | $512K | 2/5/2022 | View on chart |
| RTX | ▼ Sell | Tax Withholding | 4,770 | $444K | 2/5/2022 | View on chart |
| RTX | ▲ Buy | Option Exercise | 15,046 | $0 | 2/5/2022 | View on chart |
| RTX | ▲ Buy | Option Exercise | 10,287 | $0 | 2/5/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
3M to challenge $1.4B Australian PFAS lawsuit ahead of Q3 earnings
3M is preparing to challenge Australia's $1.4 billion PFAS contamination lawsuit, a major legal development for the company. At the same time, market participants are looking ahead to 3M's upcoming third-quarter earnings, with Wall Street projections offering insights into key metrics. The stock is currently trading within its 52-week range, with an average analyst target of $186.15.
3M to challenge $1.4B Australian PFAS lawsuit ahead of Q3 earnings. 3M is preparing to challenge Australia's $1.4 billion PFAS contamination lawsuit, a major legal development for the company. At the same time, market participants are looking ahead to 3M's upcoming third-quarter earnings, with Wall Street projections offering insights into key metrics. The stock is currently trading within its 52-week range, with an average analyst target of $186.15.